|
This letter appeared in the Canadian Medical Association
Journal on July 11, 2000; 163(1):14.
CORRESPONDENCE:
HIV infection and risk behaviours in young gay and
bisexual men
Robert S. Hogg,
Steffanie A. Strathdee*, Keith Chan, Stephen L. Martindale, Kevin
JP Craib.
British Columbia Centre for Excellence in
HIV/AIDS, St. Paul's Hospital, Vancouver, BC;
and (*) Johns Hopkins School of Hygiene and Public Health, Baltimore,
Md.
In response to: R.S.
Remis,
et al.
We recalculated the HIV infection rate based on all years and
on whether a subject had reported that they had ever injected
drugs. These new person-time estimates of HIV incidence are based
on 18 subjects who became HIV positive after their baseline seronegative
test, 8 more than in our published study [Research]1
and excluding the person with the baseline indeterminate result.
The incidence rate has been revised to 1.2 per 100 person-years
(95% CI 0.61.7) (Table
1) since the paper was written. Gay and bisexual men who
injected drugs have a higher incidence rate (3.1 per 100 person-years
[95% CI 0.66.1]) than those who did not (0.9 per 100 person-years
[95% CI 0.41.4]). Robert Remis and colleagues are correct
in assuming that our rate of HIV incidence among noninjecting
participants is similar to that reported for men under 30 years
in the Omega
cohort(1.0 per 100 person-years from 1996 to 1999). However,
the annualized incidence rates presented in Table
1 for noninjecting gay and bisexual men indicate that
HIV infection appears to be increasing in this population.
Remis and colleagues felt that we should have reported follow-up
risky sexual behaviour among participants who had safe as well
as unsafe sexual practices at baseline. Of the 285 men with regular
partners, 89 (31.2%) reported having unprotected insertive anal
sex and 100 (35.0%) reported having unprotected receptive anal
sex in the year before the baseline visit. At 1-year follow-up,
66 (74.1%) of the 89 subjects and 71 (71.0%) of the 100 subjects
reported having unprotective insertive and receptive anal sex
respectively. Of the 279 men with casual partners, 46 (16.5%)
reported having unprotected insertive and 36 (12.4%) unprotected
receptive anal sex in the year before the baseline visit. Of these
men, 21 (46.6%) and 16 (44.4%) reported having had unprotected
insertive and receptive anal intercourse respectively by the time
of their first follow-up visit. In combining these data with other
information presented in our paper,1 the odds of relapseamong
men with regular partners increased 2-fold for both unprotected
insertive intercourse (odds ratio 2.2, 95% CI 1.4-3.7) and receptive
anal intercourse (odds ratio 1.9, 95% CI 1.4-3.0). Among men with
casual partners, similar odds were observed for unprotected insertive
intercourse (odds ratio 1.7, 95% CI 1.02.8), but the odds
for receptive anal intercourse were not significantly increased
(odds ratio 1.3, 95% CI 0.72.3). These new data along with
the findings originally presented in our article confirm the high
HIV rates and sexual risk behaviour in our cohort.
Table 1:
Incidence of HIV infection among study participants, by study
year and category
|
All participants (n = 617) |
Noninjection drug users (n = 555) |
Injection drug users (n = 61) |
| Study year |
New infections |
Rate
(95% CI) |
New infections |
Rate
(95% CI) |
New infections |
Rate
(95% CI) |
| 1 |
1 |
1.0
(0.02.8) |
1 |
1.0
(0.03.1) |
0 |
|
| 2 |
6 |
1.7
(0.33.1) |
3 |
0.9
(0.02.0) |
3 |
11.4
(0.024.3) |
| 3 |
2 |
0.5
(0.01.1) |
1 |
0.2
(0.00.7) |
1 |
3.2
(0.09.4) |
| 4 |
5 |
1.2
(0.12.2) |
4 |
1.0
(0.02.0) |
0 |
|
| 5 |
4 |
1.8
(0.03.6) |
4 |
2.0
(0.04.1) |
0 |
|
| All years |
18* |
1.2
(0.61.7) |
13 |
0.9
(0.41.4) |
4 |
3.1
(0.66.1) |
|
* Data regarding injection drug
use were unavailable for 1 seroconverter, who was identified
through anonymous database linkage. |
[back to text]
REFERENCE:
1. Strathdee SA, Martindale SL, Cornelisse
PGA, Miller ML, Craib KJP, Schechter MT, et al. HIV infection and risk behaviours among
young gay and bisexual men in Vancouver. CMAJ 2000;162(1):21-5.
© 2000 Canadian Medical Association
or its licensors
For more information, contact:
Bonnie Devlin
Vanguard Project Coordinator
608 - 1081 Burrard Street
Vancouver, BC, Canada, V6Z 1Y6
Tel: (604)806-8306
Fax: (604)806-9044
|